| __timestamp | GSK plc | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7323000000 | 54823000000 |
| Thursday, January 1, 2015 | 8853000000 | 76691000000 |
| Friday, January 1, 2016 | 9290000000 | 87477000000 |
| Sunday, January 1, 2017 | 10342000000 | 89052000000 |
| Monday, January 1, 2018 | 10241000000 | 100745000000 |
| Tuesday, January 1, 2019 | 11863000000 | 91915000000 |
| Wednesday, January 1, 2020 | 11704000000 | 95905000000 |
| Friday, January 1, 2021 | 11603000000 | 104442000000 |
| Saturday, January 1, 2022 | 9554000000 | 104437000000 |
| Sunday, January 1, 2023 | 8565000000 | 112009000000 |
| Monday, January 1, 2024 | 121134000000 |
Unleashing the power of data
In the ever-evolving landscape of global commerce, GSK plc and Walgreens Boots Alliance, Inc. stand as titans in their respective industries. From 2014 to 2023, Walgreens consistently outpaced GSK in cost of revenue, with figures peaking at over 120% higher in 2023. This trend highlights Walgreens' expansive operations and market reach, particularly in the healthcare and retail sectors. GSK, a leader in pharmaceuticals, saw a more modest increase, with its cost of revenue peaking in 2019 before a slight decline. The data reveals a fascinating narrative of growth and strategic shifts, with Walgreens' cost of revenue showing a steady upward trajectory, while GSK's figures reflect a more fluctuating pattern. Notably, 2024 data for GSK is missing, leaving room for speculation on future trends. This comparison offers a unique insight into the financial strategies and market dynamics of these two industry leaders.
Cost Insights: Breaking Down Novo Nordisk A/S and Walgreens Boots Alliance, Inc.'s Expenses
Cost Insights: Breaking Down Gilead Sciences, Inc. and GSK plc's Expenses
Cost Insights: Breaking Down GSK plc and Insmed Incorporated's Expenses
GSK plc vs Jazz Pharmaceuticals plc: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: GSK plc vs Veracyte, Inc.
GSK plc vs MiMedx Group, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Viatris Inc. and Walgreens Boots Alliance, Inc.'s Expenses
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs Walgreens Boots Alliance, Inc.
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Alkermes plc's Expenses
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Trends: Walgreens Boots Alliance, Inc. vs Amphastar Pharmaceuticals, Inc.